A Clyzerin, wasserfrei [German] CEP of the European Pharmacopoeia monograph is often referred to as a Clyzerin, wasserfrei [German] Certificate of Suitability (COS). The purpose of a Clyzerin, wasserfrei [German] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clyzerin, wasserfrei [German] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clyzerin, wasserfrei [German] to their clients by showing that a Clyzerin, wasserfrei [German] CEP has been issued for it. The manufacturer submits a Clyzerin, wasserfrei [German] CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clyzerin, wasserfrei [German] CEP holder for the record. Additionally, the data presented in the Clyzerin, wasserfrei [German] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clyzerin, wasserfrei [German] DMF.
A Clyzerin, wasserfrei [German] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clyzerin, wasserfrei [German] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clyzerin, wasserfrei [German] suppliers with CEP (COS) on PharmaCompass.